Cargando…

The unfinished story of hydroxychloroquine in COVID-19: The right anti-inflammatory dose at the right moment?

Detalles Bibliográficos
Autores principales:	Dauby, Nicolas, Bottieau, Emmanuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567655/ https://www.ncbi.nlm.nih.gov/pubmed/33075529 http://dx.doi.org/10.1016/j.ijid.2020.10.032

Ejemplares similares

Reply to ‘Low‐dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID‐19: association does not mean causality’
por: Dauby, N., et al.
Publicado: (2021)

Reply to “The perceived efficacy of hydroxychloroquine in observational studies: the results of the confounding effects of ‘goals of care’”
por: Dauby, Nicolas, et al.
Publicado: (2021)

Covid-19, an unfinished story
por: Buisson, Yves
Publicado: (2022)

COVID-19 and Unfinished Mourning
por: Farahmandnia, Behnam, et al.
Publicado: (2020)

COVID-19: Hydroxychloroquine prophylaxis is just a prophylaxis! Be careful and perceive it right
por: Garg, Rakesh, et al.
Publicado: (2022)

An unfinished story : gender patterns in media employment
por: Gallegher, Margaret
Publicado: (1995)

Bias, the unfinished symphony
por: Coşkun, Abdurrahman
Publicado: (2022)

Finding the right time for anti-inflammatory therapy in COVID-19
por: de Simone, Giovanni, et al.
Publicado: (2020)

The Human Transcriptome: An Unfinished Story
por: Pertea, Mihaela
Publicado: (2012)

Humidifier disinfectants, unfinished stories
por: Choi, Yeyong, et al.
Publicado: (2016)

Escalation to high‐flow nasal cannula oxygen in hematological malignancy: the right choice at the right moment?
por: Buonanno, Pasquale, et al.
Publicado: (2022)

Viral hepatitis in Saudi Arabia: An unfinished story
por: Abdo, Ayman A., et al.
Publicado: (2015)

Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants
por: Catteau, Lucy, et al.
Publicado: (2020)

The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19
por: Sadasivam, Balakrishnan, et al.
Publicado: (2020)

Mobilizing Against AIDS: The Unfinished Story of a Virus
por: Jekel, James F.
Publicado: (1987)

John squire and endothelial glycocalyx structure: an unfinished story
por: Arkill, Kenton P., et al.
Publicado: (2022)

Therapeutic drug monitoring in inflammatory bowel disease: At the right time in the right place
por: Truta, Brindusa
Publicado: (2022)

It is time to consider an anti-inflammatory therapy based on the pathophysiology of COVID-19 infection during the right time window?
por: Ghanei, Mostafa
Publicado: (2021)

Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19: association does not mean causality
por: De Schryver, Nicolas, et al.
Publicado: (2021)

Comment on: COVID-19 and abortion right
por: Omidinia, Eskandar
Publicado: (2021)

Comment on: COVID-19 and abortion right
por: Madani, Seyyed Javad, et al.
Publicado: (2021)

Right ventricular dysfunction in COVID-19
por: Bhattacharyya, Amrita, et al.
Publicado: (2022)

Psychiatric adverse events with hydroxychloroquine during COVID-19 pandemic
por: Emmanuel, Stip, et al.
Publicado: (2020)

Re: ‘ESCMID COVID-19 living guidelines: drug treatment and clinical management’ by Bartoletti et al
por: Dauby, Nicolas
Publicado: (2022)

Right Place, Right Time: Serendipitous Opportunities in a Urology Fellowship Disrupted by the COVID-19 Pandemic
por: Chowdhury, Md Ashif, et al.
Publicado: (2020)

SARS-CoV-2 variants, a still unfinished story()
por: Pérez-Abeledo, M., et al.
Publicado: (2021)

Thrombotic microangiopathy: COVID-19 or hydroxychloroquine?
por: Hasbal, Nuri Baris
Publicado: (2020)

Hydroxychloroquine, TTP, COVID-19, and SLE
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Doing the right thing for the right reason when treating ruptured abdominal aortic aneurysms in the COVID-19 era
por: Verikokos, Christos, et al.
Publicado: (2020)

Are Genetic Vaccines the Right Weapon against COVID-19?
por: Conforti, Antonella, et al.
Publicado: (2020)

Right Ventricular Dysfunction in COVID-19 ECMO—A Red Herring or the Real Deal?
por: Kopanczyk, Rafal, et al.
Publicado: (2022)

Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic()
por: Jáuregui, Edwin
Publicado: (2021)

Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients
por: Mahmoudi, Javad, et al.
Publicado: (2021)

Letter to the editor: The effect of hydroxychloroquine on COVID-19
por: Demir, Canan, et al.
Publicado: (2022)

Analysis of hydroxychloroquine prescriptions for COVID‐19 in Japan
por: Watari, Takashi, et al.
Publicado: (2023)

Hydroxychloroquine at usual doses as an option for coronavirus disease 2019 treatment
por: Carbillon, Lionel, et al.
Publicado: (2021)

Epidemiology and Control of Meningococcal Disease in Canada: A Long, Complex, and Unfinished Story
por: De Wals, Philippe
Publicado: (2019)

Human rights and rethinking the use of “Mandatory” during COVID-19
por: Yu, B.J., et al.
Publicado: (2022)

Unexplained Acute Right Ventricular Dilatation and Dysfunction in COVID-19
por: Ezhilkugan, G., et al.
Publicado: (2021)

Novel approach for low‐dose pulmonary delivery of hydroxychloroquine in COVID‐19
por: Fassihi, Safa C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_seo99lmf1euvkpumlnnq89rqkr